CSCI

COSCIENS Biopharma Inc. Common Stock
CSCI

Overview Fund Activity
Delisted

CSCI was delisted on the 3rd of September, 2025.

Back to rankings

18 hedge funds and large institutions have $969K invested in COSCIENS Biopharma Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+5
Holders Change %
+38.46%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
2
Reduced
1
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$476K
2
NCCM
Nine Chapters Capital Management
New Jersey
+$122K
3
Two Sigma Investments
Two Sigma Investments
New York
+$61K
4
Citadel Advisors
Citadel Advisors
Florida
+$54K
5
Morgan Stanley
Morgan Stanley
New York
+$47.1K

Top Sellers

1
AG
Aperio Group
California
-$82K
2
Jane Street
Jane Street
New York
-$52K
3
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$43K
4
TRCT
Tower Research Capital (TRC)
New York
-$25K
5
Bank of America
Bank of America
North Carolina
-$23K
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
– -$25K -2 Closed
NFG
27
Next Financial Group
Texas
– -$8K -1 Closed
JT
28
Jump Trading
Illinois
– -$1K – –
1
2